BIOMAT Database Logo BIOMAT Database Logo

The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. 1986

J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002795 Choline O-Acetyltransferase An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. Choline Acetylase,Choline Acetyltransferase,Acetylase, Choline,Acetyltransferase, Choline,Choline O Acetyltransferase,O-Acetyltransferase, Choline
D002799 Cholinergic Fibers Nerve fibers liberating acetylcholine at the synapse after an impulse. Cholinergic Fiber,Fiber, Cholinergic,Fibers, Cholinergic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D013377 Substantia Innominata Tissue in the BASAL FOREBRAIN inferior to the anterior perforated substance, and anterior to the GLOBUS PALLIDUS and ansa lenticularis. It contains the BASAL NUCLEUS OF MEYNERT. Innominata, Substantia

Related Publications

J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
A subcortico-cortical cholinergic system is affected in Parkinson's disease.
December 1983, Brain research,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
December 1983, Journal of the neurological sciences,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Extraneural cholinergic markers in Alzheimer's and Parkinson's disease.
January 1986, Progress in neuro-psychopharmacology & biological psychiatry,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
The cholinergic system in Alzheimer's disease.
August 1997, Progress in neurobiology,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Targeting the cholinergic system in Parkinson's disease.
April 2020, Acta pharmacologica Sinica,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Alzheimer's disease, anesthesia and the cholinergic system.
April 2011, Journal of anaesthesiology, clinical pharmacology,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Alzheimer's disease: Targeting the Cholinergic System.
January 2016, Current neuropharmacology,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.
April 1991, Journal of neurology, neurosurgery, and psychiatry,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Progression of regional cortical cholinergic denervation in Parkinson's disease.
January 2022, Brain communications,
J M Candy, and E K Perry, and R H Perry, and J A Court, and A E Oakley, and J A Edwardson
Cortical glucose metabolism in Parkinson's and Alzheimer's disease.
December 1990, Journal of neuroscience research,
Copied contents to your clipboard!